Back
Sonnet BioTherapeutics Holdings Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
SONN
Sonnet BioTherapeutics Holdings
Last Price:
$6.22
Seasonality Move:
-20.08%
7 Day Trial
ALL ACCESS PASS
$
7
Sonnet BioTherapeutics Holdings Stock Forecast
-
Over the next 52 weeks, Sonnet BioTherapeutics Holdings has on average historically fallen by 32.8% based on the past 17 years of stock performance.
-
Sonnet BioTherapeutics Holdings has fallen lower in 15 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 88.24%
-
Is Sonnet BioTherapeutics Holdings Stock Undervalued?The current Sonnet BioTherapeutics Holdings [SONN] share price is $6.18. The Score for SONN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SONN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sonnet BioTherapeutics Holdings Stock Go Up Next Year?
-
Over the next 52 weeks, Sonnet BioTherapeutics Holdings has on average historically fallen by 32.8% based on the past 17 years of stock performance.
Sonnet BioTherapeutics Holdings Stock Rating
Sell
42
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings overpriced?
-
Sonnet BioTherapeutics Holdings has fallen lower in 15 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 88.24%
Sonnet BioTherapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sonnetbio.com
52-Week Data
52-Week High:
19.30
52-Week Low:
1.08
Prediction Charts
Market Cap:
19.6M
Price in USD:
6.18
Volume:
1.6M
Beta:
0.64
Technical Analysis
SMA50:
2.40
SMA100:
1.88
SMA200:
2.38
52-Wk Change:
-10.18%
Stock Predictions
-
Is Sonnet BioTherapeutics Holdings stock public?Yes, Sonnet BioTherapeutics Holdings is a publicly traded company.
-
What is the Sonnet BioTherapeutics Holdings stock quote today?The Sonnet BioTherapeutics Holdings stock price is 6.18 USD today.
-
How to buy Sonnet BioTherapeutics Holdings stock online?You can buy Sonnet BioTherapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-30 | 1.13 | 1.25 | 1.25 | 1.11 |
Jul-1 | 1.23 | 1.21 | 1.28 | 1.21 |
Jul-2 | 1.30 | 4.16 | 4.40 | 1.30 |
Jul-3 | 3.65 | 3.92 | 4.14 | 3.10 |
Jul-7 | 5.74 | 4.73 | 6.00 | 4.54 |
Jul-8 | 5.09 | 4.47 | 5.66 | 4.32 |
Jul-9 | 4.52 | 4.64 | 5.10 | 4.32 |
Jul-10 | 4.61 | 5.28 | 5.39 | 4.19 |
Jul-11 | 5.40 | 5.17 | 5.67 | 4.86 |
Jul-14 | 15.03 | 9.64 | 19.30 | 7.78 |
Jul-15 | 8.32 | 9.77 | 10.38 | 7.63 |
Jul-16 | 9.45 | 8.61 | 10.34 | 8.25 |
Jul-17 | 8.11 | 7.79 | 8.57 | 7.14 |
Jul-18 | 7.51 | 6.18 | 7.59 | 5.90 |
Sonnet BioTherapeutics Holdings Earnings
Sonnet BioTherapeutics Holdings Earnings Report: Per Share Sonnet BioTherapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sonnet BioTherapeutics Holdings Forecast Revenue Growth
Sonnet BioTherapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Sonnet BioTherapeutics Holdings and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $10.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.42 per share, and a decrease next year of $0.00 per share.
* Sonnet BioTherapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.